Ledger.Open graph →
SEC Form D · filed August 10, 2016

ONL Therapeutics, Inc

Offering
$1.2M
Sold
$916K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

John K. Freshley · Ann Arbor, MIExec · DirectorDavid N. Zacks · Ann Arbor, MIExec · DirectorMark K. Hooper · Ann Arbor, MIDirectorLoic K. Couraud · Ann Arbor, MIDirectorWilliam K. Brinkerhoff · Ann Arbor, MIDirectorRobert Seidel · BURBANK, CADirectorTyler Reynolds · New Haven, CTDirectorJohn Suh · BURBANK, CADirectorJonathan R. Asmis · San Francisco, CAExec · DirectorStephen G. Shaya · Mill Valley, CADirectorJimmie A. Harvey, Jr · New York, NYExec · DirectorMalcolm A. Hoenlein · New York, NYDirectorJ. J. Lobell · New York, NYExec · DirectorArthur Loomis · Latham, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗